Chapter 8 160 References 1. Chang, A.Y., V.F. Skirbekk, S. Tyrovolas, N.J. Kassebaum, and J.L. Dieleman, Measuring population ageing: an analysis of the Global Burden of Disease Study 2017. Lancet Public Health, 2019. 4(3), e159-e167 DOI: 10.1016/s24682667(19)30019-2. 2. Lancet, T. Patient empowerment - who empowers whom? The Lancet, 2012. 379, 1677 DOI: 10.1016/S0140-6736(12)60699-0. 3. Anderson, G., Responding to the growing cost and prevalence op people with multiple chronic conditions. 2007, Johns Hopkins Bloomwerg school of public health. 4. Stolz, D., T. Mkorombindo, D.M. Schumann, A. Agusti, S.Y. Ash, M. Bafadhel, et al., Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. The Lancet, 2022. 400(10356): p. 921-972. 5. Celli, B., L. Fabbri, G. Criner, F.J. Martinez, D. Mannino, C. Vogelmeier, et al., Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am J Respir Crit Care Med, 2022. 206(11):1317–1325. 6. Aujoulat, I., R. Marcolongo, L. Bonadiman, and A. Deccache, Reconsidering patient empowerment in chronic illness: a critique of models of self-efficacy and bodily control. Soc Sci Med, 2008. 66(5): p. 1228-39. 7. Bodenheimer, T., E.H. Wagner, and K. Grumbach, Improving primary care for patients with chronic illness. JAMA, 2002. 288(14), 1775-1779 DOI: 10.1001/jama.288.14.1775. 8. Hoogendoorn, M., C.R. van Wetering, A.M. Schols, and M.P. Rutten-van Mölken, Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) costeffective? Eur Respir J, 2010. 35(1): p. 79-87. 9. Boland, M.R., A. Tsiachristas, A.L. Kruis, N.H. Chavannes, and M.P. Rutten-van Mölken, The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis. BMC Pulm Med, 2013. 13: p. 40. 10. Spruit, M.A., S.J. Singh, C. Garvey, R. Zu-Wallack, L. Nici, C.L. Rochester, et al., An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation. Am J Respir Crit Care Med, 2013. 188(8): p. e13-e64. 11. KNGF, Guideline COPD. 2020, Drukkerij De Gans: Amersfoort. 12. Sabaté, E., Adherence to long-term therapies. Evidence for action 2003, Geneva: World Health Organization. 13. Blackstock, F.C., R.Z. Wallack, L. Nici, and S.C. Lareau, Why don't our patients with chronic obstructive pulmonary disease listen to us? the enigma of nonadherence. Annals of the American Thoracic Society, 2016. 13(3): p. 317-323. 14. Meichenbaum, D. and D. Turk, Facilitating treatment adherence. 1987, New York: Plenum. 15. Thornton, J.S., P. Frémont, and K. Khan, Physical activity prescription: a critical opportunity to address a modifiable risk factor for the prevention and management of chronic disease: a position statement by the Canadian Academy of Sport and Exercise Medicine. British Journal of Sports Medicine, 2016. 50: p. 1109-1114. 16. Holman, H. and K. Lorig, Patient self-management: a key to effectiveness and efficiency in care of chronic disease. Public Health Rep, 2004. 119(3): p. 239-43.
RkJQdWJsaXNoZXIy MjY0ODMw